Pipeline · Bristol-Myers Squibb Co
47 products
Marketed(atazanavir sulfate + cobicistat)Evotaz ((atazanavir sulfate + cobicistat))Marketed(hyaluronidase (recombinant, human) + nivolumab)Opdivo Qvantig ((hyaluronidase-nvhy (recombinant, human) + nivolumab))Marketed(nivolumab + relatlimab)Opdualag ((nivolumab + relatlimab-rmbw))Marketed(trospium chloride + xanomeline tartrate)Cobenfy ((trospium chloride + xanomeline tartrate))MarketedAzactamAzactam (aztreonam)MarketedLENALIDOMIDELENALIDOMIDE (LENALIDOMIDE)MarketedOnuregOnureg (azacitidine)MarketedReyatazReyataz (atazanavir sulfate)MarketedabataceptOrencia (abatacept)MarketedadagrasibKrazati (adagrasib)Marketedapixaban ODTEliquis (apixaban)MarketedbelataceptNulojix (belatacept)MarketeddeucravacitinibSotyktu (deucravacitinib)MarketedelotuzumabEmpliciti (elotuzumab)Marketedenasidenib mesylateIdhifa (enasidenib mesylate)MarketedfedratinibInrebic (fedratinib)MarketedipilimumabYervoy (ipilimumab)MarketedmavacamtenCamzyos (mavacamten)MarketednivolumabOpdivo (nivolumab)MarketedrepotrectinibAugtyro (repotrectinib)Phase 3admilparantPhase 3arlocabtagene autoleucelPhase 3danicamtivPhase 3ipilimumab + nivolumabOpdivo + Yervoy (ipilimumab + nivolumab)Phase 3izalontamab brengitecanPhase 3mezigdomidePhase 3milvexianPhase 3sitravatinib malatePhase 2(atigotatug + nivolumab)(atigotatug [INN] + nivolumab)Phase 2BMS-986446